To verify whether CDK1 mediates the pro-oncogenic effect of ABCC5 in prostate cancer, we knocked down CDK1 again in prostate cancer cells overexpressing ABCC5 and performed a series of tumor phenotyping experiments. The gene discussed is ABCC5; the disease is Familial prostate cancer.